January 10, 2022
Regeneron Pharmaceuticals can see U.S Food and Drug Administration documents that the company says could undermine claims it paid illegal kickbacks to doctors who prescribed its eye disease drug, a Boston federal judge said Monday.
December 04, 2020
Regeneron Pharmaceuticals Inc. must face claims that the millions of dollars it funneled to a patient-support charity were kickbacks meant to convince doctors to prescribe its pricey eye disease drug, a Massachusetts federal judge ruled Friday.
October 07, 2020
Regeneron Pharmaceuticals on Wednesday pressed a judge to dismiss claims it shelled out kickbacks to get doctors to prescribe its injectable eye disease drug through a co-pay foundation, arguing the federal government's legal theory would render virtually all charitable payments illegal.
September 22, 2020
The federal government has urged a Massachusetts federal judge not to toss its suit accusing Regeneron Pharmaceuticals of paying illegal kickbacks to get doctors to prescribe its injectable eye disease drug, arguing that the biotechnology company is using a "legally irrelevant" argument.
August 24, 2020
Federal prosecutors in Massachusetts can't prevail in their suit accusing Regeneron Pharmaceuticals of paying tens of millions of dollars in illegal kickbacks through a foundation to get doctors to prescribe its injectable eye disease drug, the biotechnology company has told a federal judge.
June 24, 2020
Federal prosecutors in Massachusetts accused New York pharmaceutical company Regeneron Pharmaceuticals on Wednesday of paying tens of millions of dollars in illegal kickbacks through a foundation to get doctors to prescribe its injectable eye disease drug.